Anti-Malarial drug HCQ does not reduce COVID-19 mortality rate


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ antimalarial-drug-hcq-reduce-covid19-mortality-rate
The announcement comes two days after the US revoked emergency use status of both hydroxychloroquine and chloroquine to treat the new coronavirus.

The World Health Organization said it had concluded Wednesday to end preliminaries of hydroxychloroquine as a likely treatment for COVID-19 patients, discovering it didn't diminish the death rate.

Specialist Ana Maria Henao Restrepo, from the WHO's wellbeing crises program, told a virtual question and answer session in Geneva that the antimalarial sedate was being pulled back from its multi-nation Solidarity Trial of possible medicines.

"The inward proof from the Solidarity/Discovery Trial, the outside proof from the Recovery Trial and the joined proof from these enormous randomized preliminaries, united, recommend that hydroxychloroquine - when contrasted and the standard of care in the treatment of hospitalized COVID-19 patients - doesn't bring about the decrease of the mortality of those patients," she said.

"In view of this examination and on the audit of the distributed proof, the Executive Group of the Solidarity/Recovery Trial has met on two events and today we met with all the foremost specialists.

"After consideration, they have inferred that the hydroxychloroquine arm will be halted from the Solidarity Trial."

The declaration came two days after the United States pulled back crisis use authorizations for both hydroxychloroquine and chloroquine, two antimalarial drugs supported by President Donald Trump to treat the new coronavirus.

Tags : #HCQ #Antimalarial #COVID-19

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026